NEW PRODUCT · IN DEVELOPMENT

आकाशात् पतितं तोयं यथा गच्छति सागरम्

Ākāśāt Patitaṁ Toyaṁ Yathā Gacchati Sāgaram

"As waters fallen from the heavens return to the ocean — so does cosmic knowledge return to humanity."

MedhSpacLiHeaX

Space Health Platform · MAARP

Earth's medicine, manufactured and validated in orbit. Sovereign biology beyond gravity.

PharmaVita
WHAT IT IS

A new sovereign capability.

MedhSpacLiHeaX extends the sovereign biology platform into orbit. The MAARP architecture hosts miniaturized lab-on-chip experiments, organoid and tissue-chip studies, and surgical-containment research in microgravity — opening science that gravity-bound labs cannot execute.

Microgravity research platform (MAARP) for miniaturized lab-on-chip, tissue chips, and surgical containment systems in space.

RIDES ON THE ONE PLATFORM

Built on the GAMIE intelligence core.

Orbital experiments feed twin-validated hypotheses back into VAIKUNTHA and downstream Pharma / Vita research workflows. GAMIE handles ingest, reconciliation, and reasoning over orbital datasets.

Engines powering MedhSpacLiHeaX

  • MEDHxAKAZE
  • MEDHxRESTNET50
  • MEDHxBERT
Read the platform architecture
CAPABILITIES

What ships inside MedhSpacLiHeaX.

01

MAARP microgravity research platform

Mission-ready architecture for sovereign in-orbit biology research.

02

Lab-on-chip miniaturization

Flight-grade miniaturization of chemistry, assay, and analytics — engineered for sovereign IP control.

03

Tissue chip and organoid programs

Microgravity-resolved organoid biology that gravity-bound labs simply cannot reproduce.

04

Surgical containment research

Containment and instrumentation research for surgical-grade procedures in orbit.

05

Sovereign in-orbit data residency

Telemetry and result streams routed to sovereign ground stations, not foreign clouds.

STRATEGIC IMPACT

Sovereign-relevant by design.

Sovereign space agencies and pharma champions co-develop an orbital biology corridor — a strategic asset class no Earth-bound competitor can replicate.

Customer profiles

  • 01Sovereign space agencies
  • 02National pharma champions
  • 03Defense bioscience directorates
  • 04Tier-1 academic-clinical alliances
DEVELOPMENT STATUS

In active research and development.

Sovereign design partners are being onboarded selectively. Reach out to align on capability fit and deployment cadence.

In development
PARTNER WITH MEDHINI

Co-develop MedhSpacLiHeaX as a sovereign asset.